The Use of OKT3 in Cadaveric Renal Transplantation for Rejection That Is Unresponsive to Conventional Anti-Rejection Therapy
- 1 February 1988
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 11 (2) , 90-93
- https://doi.org/10.1016/s0272-6386(88)80186-0
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- OKT3 TREATMENT OF STEROID-RESISTANT RENAL ALLOGRAFT REJECTIONTransplantation, 1987
- Therapeutic Use of OKT3 Monoclonal Antibody for Acute Renal Allograft RejectionNephron, 1987
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- EVOLVING USE OF OKT3 MONOCLONAL ANTIBODY FOR TREATMENT OF RENAL ALLOGRAFT REJECTIONTransplantation, 1984
- Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complexCell, 1982
- TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODYTransplantation, 1981
- Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal AllograftsNew England Journal of Medicine, 1981
- Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells?Proceedings of the National Academy of Sciences, 1981
- Monoclonal Antibodies Defining Distinctive Human T Cell Surface AntigensScience, 1979